Calcium dobesilate efficiency in the treatment of diabetic kidney disease through suppressing MAPK and chemokine signaling pathways based on clinical evaluation and network pharmacology

Aims: To evaluate the effectiveness and potential mechanism of calcium dobesilate (CaD) in diabetic kidney disease (DKD) patients. Methods: We searched for available randomized controlled studies on DKD patients’ treatment with CaD through open databases. Continuous variables were expressed as stand...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Bingyu, Yin, Yanyan, Wang, Yuqing, Fu, Hui, Sun, Helin, Yue, Zhaodi, Yu, Shaohong, Zhang, Zhongwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493050/
https://www.ncbi.nlm.nih.gov/pubmed/36160448
http://dx.doi.org/10.3389/fphar.2022.850167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493050/
https://www.ncbi.nlm.nih.gov/pubmed/36160448
http://dx.doi.org/10.3389/fphar.2022.850167

Ejemplares similares